UMAC Filing
4Filing Date: Jul 28, 2026

Unusual Machines, Inc. (UMAC) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001683168-26-005807open_in_new
Total Value$0
Trades1
Insiders1

Transaction Details

Camden Andrew Ross
President·Direct
Grant · Acquire
Stock Options (Right to Buy)Derivative
Shares+525.00K
Price$0.00
Total Value$0
Shares Owned After525.00K
Transaction DateJul 24, 2026
ExpiresJul 24, 2031
Footnotes ▸

The stock options reported herein were granted pursuant to the Issuer's 2022 Equity Incentive Plan. The grant was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated thereunder, having been approved by the Compensation Committee of the Issuer's Board of Directors. The options vest in equal quarterly installments over a three-year period from the grant date, in each case subject to the Reporting Person's continued employment with the Issuer or a subsidiary through the applicable vesting date.

Post-Transaction Holdings

Camden Andrew Ross
SecuritySharesChange
Stock Options (Right to Buy)525.00K+525.00K
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-07-24 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Unusual Machines, Inc. (UMAC) CIK: 0001956955 --- Reporting Owner --- Name: Camden Andrew Ross CIK: 0002014748 Role: Officer (President) --- Derivative Transactions --- [Transaction #1] Security: Stock Options (Right to Buy) Date: 2026-07-24 | Code: A (Grant or award) Shares: +525,000 | Price: $0.00 Exercisable: N/A | Expires: 2031-07-24 Shares Owned After: 525,000 | Ownership: D (Direct) Footnotes: [F1] The stock options reported herein were granted pursuant to the Issuer's 2022 Equity Incentive Plan. The grant was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated thereunder, having been approved by the Compensation Committee of the Issuer's Board of Directors. The options vest in equal quarterly installments over a three-year period from the grant date, in each case subject to the Reporting Person's continued employment with the Issuer or a subsidiary through the applicable vesting date. --- Footnotes (Complete Index) --- F1: The stock options reported herein were granted pursuant to the Issuer's 2022 Equity Incentive Plan. The grant was exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated thereunder, having been approved by the Compensation Committee of the Issuer's Board of Directors. The options vest in equal quarterly installments over a three-year period from the grant date, in each case subject to the Reporting Person's continued employment with the Issuer or a subsidiary through the applicable vesting date. --- Signature --- /s/ /s/ Andrew Camden (2026-07-28)

keid analysis is for reference only and does not constitute investment advice.